2017-03-15,Amarin Announces Publication Of REDUCE-IT Cardiovascular Outcomes Study Rationale And Design In Clinical Cardiology
2017-02-28,Biotech Premarket Movers: Cempra, Novavax, Ionis
2017-02-28,Amarin Reports Record Fourth Quarter And Full Year 2016 Financial Results And Provides Update On Operations
2017-02-22,Interesting AMRN Call Options For May 19th
2017-02-22,Amarin To Report Fourth Quarter And Full Year 2016 Results And Host Conference Call On February 28th, 2017
2017-02-09,Amarin To Participate In The Leerink Partners 6th Annual Global Healthcare Conference
2017-01-20,Amarin Announces Debt Restructuring And Related Private Placement Of Exchangeable Senior Notes
2017-01-05,Amarin Provides Preliminary 2016 Results And 2017 Outlook
2016-12-16,Amarin Announces Contractual Reminder Of Optional Put To Holders Of $15.1 Million Principal Amount Of Outstanding 3.50% Exchangeable Senior Notes Due 2032
2016-11-14,Pure EPA Vascepa® (icosapent Ethyl) Showed Reductions In Potentially Atherogenic Lipid And Inflammatory Parameters In Statin-Treated Women With Persistent High Triglycerides
2016-11-11,Amarin To Present At The Jefferies 2016 London Healthcare Conference
2016-11-03,Amarin Reports Third Quarter 2016 Financial Results And Provides Update On Operations
2016-10-27,Amarin To Report Third Quarter 2016 Results And Host Conference Call On November 3, 2016
2016-10-25,Pure EPA Vascepa® Now Available In New, Smaller Half-Gram Capsule Size
2016-09-12,Amarin's REDUCE-IT Cardiovascular Outcomes Study Of Vascepa To Continue As Planned At Recommendation Of Independent Data Monitoring Committee
2016-09-07,Amarin To Present At The Rodman & Renshaw 18th Annual Global Investment Conference
2016-08-31,Amarin Randomizes Final Patient Into REDUCE-IT Cardiovascular Outcomes Study Of Vascepa
2016-08-26,Amarin Announces Mandatory Exchange Of Exchangeable Senior Notes Issued In May 2014 And November 2015
2016-08-15,Amarin Announces Underwriters' Exercise Of Option To Purchase Additional American Depositary Shares
2016-08-11,Amarin (AMRN) Stock Drops After Pricing Public Offering
2016-08-11,Amarin Prices Public Offering Of American Depositary Shares
2016-08-10,Amarin Announces Proposed Public Offering Of American Depositary Shares
2016-08-02,What Do You Know? Another Down Day!
2016-06-23,Interesting AMRN Put Options For August 5th
2016-01-22,Interesting AMRN Call Options For September 16th
2015-11-12,AMRN December 31st Options Begin Trading
2015-10-29,Interesting AMRN Call Options For December 11th
2015-09-14,Tetraphase Executive Profits Hours Before Stock Plummets
2015-08-27,First Week of November 20th Options Trading For Amarin (AMRN)
2015-07-10,5 Stocks Ready for Breakouts -- Must-See Charts
2015-07-09,AMRN August 28th Options Begin Trading
2015-07-02,Interesting AMRN Call Options For August 14th
2015-06-16,3 Stocks Under $10 Making Big Moves
2015-06-11,July 31st Options Now Available For Amarin (AMRN)
2015-06-04,AMRN July 24th Options Begin Trading
2015-05-28,Amarin Surges After Court Sides With Company On Vascepa Exclusivity
2015-05-07,Interesting AMRN Put And Call Options For June 26th
2015-04-21,First Week Of AMRN December 18th Options Trading
2015-04-09,May 29th Options Now Available For Amarin (AMRN)
2015-04-02,May 22nd Options Now Available For Amarin (AMRN)
2015-03-26,Interesting AMRN Put And Call Options For May 8th
2015-03-13,3 Biotech Stocks on Traders' Radars: Technical Charts
2015-03-13,Biotech Stock Mailbag: Neuralstem, Genfit, Intercept, Amarin
2015-03-12,AMRN May 1st Options Begin Trading
2015-02-10,4 Biotech Stocks Under $10 Triggering Breakouts: Amarin, Exelixis and More
2015-02-05,5 Stocks Under $10 Set to Soar: J.C. Penney, Amarin and More
2015-01-23,Interesting AMRN Put And Call Options For September 18th
2014-12-01,5 Under-$10 Stocks Setting Up to Trade Higher: Must-See Charts
2014-11-14,Biotech Stock Mailbag: Spectrum, Intercept, Orexigen, Amarin, MannKind
2014-09-12,Why Amarin (AMRN) Stock Is Plummeting Today
2014-09-12,Third Time Was No Charm, FDA Denies Amarin Vascepa SPA Appeal
2014-09-11,Interesting AMRN Call Options For October 31st
2014-09-09,Notice To Investors In Amarin Corp. Plc's (AMRN) July 10, 2013 Public Offering: Wolf Popper LLP Announces Anticipated Filing Of Amended Complaint Against Amarin Corp. Plc (NASDAQ: AMRN)
2014-09-08,Keryx Bear Case Bolstered by Less-Than-Zippy 'Zerenex' Label
2014-09-04,AMRN October 24th Options Begin Trading
2014-08-28,October 10th Options Now Available For Amarin (AMRN)
2014-08-26,Your September Biotech Back-to-School Calendar
2014-08-21,October 3rd Options Now Available For Amarin (AMRN)
2014-08-19,Top Swing Trade Ideas for Tuesday, August 19: Apple, Zynga, More
2014-07-31,Stock Market Today: Dow Turns Negative for the Year as Earnings Gloom Sets In
2014-07-31,Amarin Shocker: There's a Reason to be Bullish Right Now
2014-06-25,Rick Harrison Of Television's "Pawn Stars®" Discusses His Revelations On Seeking Treatment For His Very High Triglycerides In National Awareness Campaign
2014-05-19,Pfizer, Forget AstraZeneca -- Check Out These Biotechs: StockTwits
2014-05-15,Why Amarin (AMRN) Stock Is Plummeting Today
2014-05-15,Amarin Announces Private Exchange Transactions Regarding Outstanding Senior Exchangeable Notes
2014-05-09,Amarin Reports First Quarter 2014 Financial Results And Provides Update On Operations
2014-05-05,Amarin To Report First Quarter 2014 Results And Host Conference Call On May 9, 2014
2014-05-02,Amarin Announces Presentation Of New MARINE And ANCHOR Post-Hoc Analyses At National Lipid Association Annual Scientific Sessions Showing Vascepa(R) Significantly Reduced Apolipoprotein C-III Levels
2014-03-31,Amarin And Kowa Pharmaceuticals America, Inc. Announce U.S. Co-Promotion Agreement For Vascepa(R) (icosapent Ethyl) Capsules
2014-03-28,3 Biotech Stocks Under $10 to Trade for Breakouts
2014-03-21,Biotech Stock Mailbag: Amarin, Cytrx, Sangamo and 'Story Stocks'
2014-03-13,5 Stocks Under $10 Set to Soar
2014-03-12,3 Stocks Under $10 Triggering Breakouts
2014-02-27,Amarin Reports Fourth Quarter And Year-End 2013 Financial Results And Provides Update On Operations
2014-02-24,Amarin Loses Bid for Vascepa 5-Year Market Exclusivity
2014-02-24,Amarin To Report Fourth Quarter And Year-End 2013 Results And Host Conference Call On February 27, 2014
2014-02-21,Amarin Announces FDA Award Of Three-Year Exclusivity For Vascepa(R) (icosapent Ethyl) Capsules
2014-02-20,Biotech Stocks to Trade for Breakouts: Amarin
2014-02-06,Amarin To Present At The 2014 Leerink Global Healthcare Conference
2014-02-05,3 Biotech Stocks Under $10 Making Big Moves
2014-02-04,Amarin Announces Promotion Of Aaron Berg To Senior Vice President, Marketing And Sales
2014-02-03,Galena, Free Fentanyl Samples and the 'Zombie Apocalypse'
2014-01-21,Amarin Announces FDA Review Division Response To ANCHOR SPA Agreement Reinstatement Request
2014-01-16,February 14th Options Now Available For Amarin (AMRN)
2014-01-15,Amarin Announces FDA Review Division Response On ANCHOR SPA Agreement Reinstatement Request Will Be Delayed
2014-01-12,Amarin Out, Intercept Pharma In at JPMorgan Healthcare Confab
2014-01-07,The Twitterverse's Biotech Stock Picks for 2014
2014-01-03,5 Stocks Poised for Breakouts
2014-01-02,AMRN January 10th Options Begin Trading
2013-12-30,The Billion-Dollar Biotech Club: Speculation Trumped Risk
2013-12-24,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors Of Class Action Against Amarin Corp. Plc And Its Board Of Directors And Of A Lead Plaintiff Deadline Of January 3, 2014
2013-12-20,DEADLINE ALERT: Rigrodsky &amp; Long, P.A. Reminds Shareholders Of Amarin Corporation Plc Of Upcoming Deadline
2013-12-20,Amarin Receives FDA Notification That Action On ANCHOR SNDA Review Will Be Delayed
2013-12-19,Interesting AMRN Call Options For December 27th
2013-12-17,The Worst Biotech CEO of 2013 Is...
2013-12-16,Amarin Announces Leadership Changes
2013-12-12,Your Vote Counts: Who Is the Worst Biotech CEO of 2013?
2013-12-06,Biotech Stock Mailbag: Enteromedics, ARCA Biopharma, Keryx Pharma
2013-12-04,4 Biotech Stocks Under $10 to Watch
2013-12-03,Amarin in Deep Hole so Top Execs Get Cash Bonus Offer
2013-12-02,Amarin Announces Notification Of Patent Allowances For U.S. Applications 13/685,281, And 13/685,291 Related To Triglyceride Lowering With A Mixture Of Omega-3 Free Fatty Acid (Including EPA And/or DHA) In Both The MARINE And ANCHOR Patient Populations
2013-11-27,SHAREHOLDER ALERT: Pomerantz Law Firm Has Filed A Class Action Against Amarin Corporation, Plc And Certain Officers - AMRN
2013-11-27,Kantrowitz, Goldhamer &amp; Graifman, P.C. Files Class Action Suit Against Amarin Corporation Plc
2013-11-27,2014 FDA Drug Approval Decision Calendar
2013-11-22,Rigrodsky &amp; Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Amarin Corporation Plc
2013-11-19,SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $150,000 In Losses From Investment In Amarin Corporation Plc To Contact Brower Piven Before The January 3, 2014 Lead Plaintiff Deadline
2013-11-19,First Week Of AMRN February 2014 Options Trading
2013-11-08,EQUITY ALERT: The Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit On Behalf Of Amarin Corporation Investors - AMRN
2013-11-08,Wolf Popper LLP Announces Continuing Investigation Into Class Action Allegations Against Amarin Corp. Plc - (AMRN)
2013-11-07,Biotech Stock Mailbag: Galectin, Keryx, Navidea, Cytori
2013-11-07,Amarin Reports Third Quarter 2013 Financial Results And Provides Update On Operations
2013-11-06,Attention Amarin Corporation Plc Investors: Amarin Corporation Plc Misled Investors According To A Newly Filed Class Action
2013-11-06,SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $150,000 In Losses From Investment In Amarin Corporation Plc To Contact Brower Piven Before The January 3, 2014 Lead Plaintiff Deadline
2013-11-06,SHAREHOLDER ALERT: Investors With More Than $50,000 In Losses From Investments In Amarin Corporation Plc Are Encouraged To Contact Wolf Haldenstein Before The January 3, 2014 Lead Plaintiff Deadline
2013-11-04,Wolf Popper LLP Announces Filing Of Class Action Lawsuit Against Amarin Corp. Plc -(AMRN)
2013-11-01,Biotech Stock Mailbag: Chelsea's FDA Panel, Ariad's Future, Bio-Bubble Update
2013-10-31,Amarin To Report Third Quarter 2013 Results And Host Conference Call On November 7, 2013
2013-10-22,Amarin Announces Plans To Reduce Expenses By Decreasing Staff Following Recent FDA Advisory Committee Vote
2013-10-17,Amarin: Dead Stock Walking With Negative Vascepa Panel Vote
2013-10-16,AMARIN CORPORATION SHAREHOLDER ALERT: The Law Firm Of Levi &amp; Korsinsky, LLP Launches An Investigation Into Claims On Behalf Of Shareholders Of Amarin Corporation In Connection With FDA Release
2013-10-16,Amarin Announces FDA Advisory Committee Outcome For The Use Of Vascepa In The Treatment Of High Triglycerides With Mixed Dyslipidemia
2013-10-16,Amarin Vascepa FDA Panel Live Blog
2013-10-16,Amarin Corporation (NASDAQ: AMRN) Stock Trading Halted Today; FDA Advisory Committee To Review SNDA For Vascepa(R) ANCHOR Indication
2013-10-15,The Essential Investor Guide to Amarin's Vascepa FDA Panel
2013-10-14,AMARIN CORPORATION SHAREHOLDER ALERT: The Law Firm Of Levi &amp; Korsinsky, LLP Launches An Investigation Into Claims On Behalf Of Shareholders Of Amarin Corporation
2013-10-14,Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Amarin Corporation Plc
2013-10-13,AMRN SHAREHOLDER ALERT: The Law Firm Of Wohl &amp; Fruchter LLP Is Investigating Amarin Corporation Plc.
2013-10-09,Amarin To Host Conference Call On October 16, 2013 To Discuss Results Of FDA Advisory Committee Meeting On ANCHOR Supplemental New Drug Application (sNDA) For Vascepa(R)
2013-10-03,Amarin Informed By FDA That October 16th Advisory Committee Meeting Will Take Place As Scheduled
2013-09-25,Amarin Announces Enrollment Of The REDUCE-IT Cardiovascular Outcomes Study Surpasses 6,000 Patients
2013-09-24,U.S. Government Shutdown Could Postpone FDA Advisory Panels
2013-09-18,Amarin To Present At The 2013 Aegis Capital Healthcare Conference
2013-09-16,Grading the Twitterverse's 2013 Biotech Stock Picks
2013-09-13,Biotech Stock Mailbag: Ariad, NewLink, Zogenix, 5 Falling Stocks For Rest of '13
2013-09-09,Amarin Announces 30th Patent For Vascepa(R)
2013-09-04,This Biotech Stock Will Gain From Your Weight Loss
2013-08-29,Finally, Some Great News For Amarin (At Arena Pharma's Expense)
2013-08-26,Amarin Announces Submission Of Supplemental New Drug Application For Novasep As Fourth Vascepa(R) Active Pharmaceutical Ingredient Supplier
2013-08-23,'Mad Money' Lightning Round: Buy, Buy, Buy LinkedIn
2013-08-23,Biotech Stock Mailbag: MannKind, Osiris, BioCryst, Vical, Amarin
2013-08-22,Cramer's 'Mad Money' Recap: Nasdaq's Integrity Outage
2013-08-22,August 30th Options Now Available For Amarin Corp (AMRN)
2013-08-21,First Week Of AMRN November 16th Options Trading
2013-08-16,5 Stocks Poised for Breakouts
2013-08-16,Stocks Wake Up After Hard Selloff
2013-08-14,4 Biotech Stocks Under $10 Making Big Moves
2013-08-13,Amarin To Present At The Canaccord Genuity 33rd Annual Growth Conference
2013-08-08,Amarin Reports Second Quarter 2013 Financial Results And Provides Update On Operations
2013-08-02,Amarin To Report Second Quarter 2013 Results And Host Conference Call On August 8, 2013
2013-07-23,First Week Of March 2014 Options Trading For Amarin Corp (AMRN)
2013-07-12,Amarin Announces Completion Of Offering Of American Depositary Shares
2013-07-09,Amarin's Stock Sale Helps Shorts Cover Winning Trade
2013-07-08,Amarin Announces Public Offering Of American Depositary Shares
2013-06-24,Amarin Corp Becomes Oversold (AMRN)
2013-06-24,Isis Drug Shuts Down Gene Causing Higher Blood-Fat Levels
2013-06-21,Amarin Announces Positive Results Of Phase 1 Clinical Trial Measuring The Bioavailability Of A Fixed-Dose Combination Of Vascepa(R) And A Statin Compared To Concomitant Administration
2013-06-19,3 Drug Stocks Poised To Move As Bears Attack
2013-06-19,Amarin: FDA Panel Date, Misplaced Hype For Fixed-Dose Combo
2013-06-19,Amarin Informed By FDA Of October 16th Advisory Committee Date In Connection With Supplemental New Drug Application (sNDA) For Vascepa(R) In The Treatment Of Patients With High Triglycerides (>200 Mg/dL And 
2013-06-06,As If Amarin Needs Another Worry, Here Comes A Vascepa FDA Panel
2013-06-06,June 14th Options Now Available For Amarin Corp Plc (AMRN)
2013-05-30,Amarin To Present At The Jefferies 2013 Global Healthcare Conference
2013-05-30,June 7th Options Now Available For Amarin Corp Plc (AMRN)
2013-05-30,Amarin Announces Additional Effects Of Vascepa(R) On Lipoprotein Particle Concentration From The ANCHOR Study Presented At The National Lipid Association 2013 Annual Scientific Sessions
2013-05-29,Doc Claims SummerStreet's Amarin Report Is Inaccurate
2013-05-28,Big Pharma Wants Fish Oil After All, But At Half Amarin's Selling Price
2013-05-24,Biotech Stock Mailbag: Amarin, MannKind, Palatin
2013-05-22,Amarin Announces Notification Of Patent Allowance For U.S. Application 13/417,899 Related To Combination Product Of Vascepa(R) And Statin Therapy
2013-05-21,Why Keryx is Lagging But Acadia is Zooming (Hint: It's About NCE)
2013-05-21,2013 FDA Drug Approval Calendar
2013-05-10,Biotech Stock Mailbag: Synta, Zogenix, Sarepta, Amarin
2013-05-09,Photo Release -- Amarin Reports First Quarter 2013 Financial Results And Provides Update On Operations
2013-05-09,Amarin Trouble Grows As Does Evidence Against Fish Oil's Benefits
2013-05-03,Amarin To Report First Quarter 2013 Results And Host Conference Call On May 9, 2013
2013-04-30,Amarin Announces Approval Of Supplemental New Drug Application For BASF As Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier
2013-04-26,Biotech Stock Mailbag: ASCO, Sarepta, Cel-Sci and Hate Mail!
2013-04-23,Futures Rise on Key Earnings
2013-04-23,Amarin Announces FDA Acceptance Of Supplemental New Drug Application (sNDA) For Vascepa(R) For The Treatment Of Patients With High Triglycerides (>200 Mg/dL And 
2013-04-22,Amarin's Fish Oil Pill Faces Even More Exclusivity Risks
2013-04-18,Amarin Announces Approval Of Supplemental New Drug Application For Chemport As Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier
